Monograph Wealth Advisors
CNTB icon

Monograph Wealth Advisors’s Connect Biopharma Holdings CNTB Stock Holding History

Monograph Wealth Advisors’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.5K Hold
11,130
– – ﹤0.01% 142
2026
Q1 		$29.2K Hold
11,130
– – ﹤0.01% 143
2025
Q4 		$31.4K Hold
11,130
– – ﹤0.01% 135
2025
Q3 		$16.8K Buy
+11,130
New +$19.7K ﹤0.01% 139

Other funds holding CNTB

Ikarian Capital
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Boothbay Fund Management
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ADAR1 Capital Management
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
Silverarc Capital Management
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.65% 1-Year Est. Return
Richmond Brothers
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

Monograph Wealth Advisors's CNTB Position: Q2 2026 in Review

Monograph Wealth Advisors held its Connect Biopharma Holdings (CNTB) position steady in Q2 2026 at 11,130 shares worth $26.5K. The position accounts for ﹤0.01% of the portfolio, ranked #142.

Monograph Wealth Advisors first reported a position in CNTB in Q3 2025 and has held it in 4 quarters since. The position peaked at $31.4K in Q4 2025. 57 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • Monograph Wealth Advisors held 11,130 shares of Connect Biopharma Holdings worth $26.5K as of Q2 2026.
  • Monograph Wealth Advisors left its Connect Biopharma Holdings share count unchanged in Q2 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Monograph Wealth Advisors's portfolio in Q2 2026, its #142 holding.
  • Monograph Wealth Advisors first reported a position in Connect Biopharma Holdings in Q3 2025 and has held it in 4 quarters since.
  • Monograph Wealth Advisors's Connect Biopharma Holdings position peaked at $31.4K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on Monograph Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.